AI in Drug Discovery

About this Research Topic

Background

Artificial intelligence (AI) is revolutionizing the fields of bioinformatics, biotechnology, and drug discovery. Drug discovery is a time-consuming and costly process, often hampered by high failure rates at various stages of development. AI technologies, including machine learning, deep learning, and natural language processing, promise to address these challenges in many different ways, from enabling the analysis of vast datasets to designing potential drug candidates —both small molecules and biologics — more efficiently than ever before.

AI-powered bioinformatics tools have the potential to predict molecular properties, optimize drug combinations, identify novel targets, generate new molecules and proteins, and personalize therapeutic interventions. By leveraging AI, researchers can explore large chemical spaces, analyse genomic data for target identification, and model complex biological systems to simulate drug responses at an unprecedented scale and speed. These advancements are not only accelerating the drug discovery process but also significantly reducing costs and improving the likelihood of successful outcomes.

The application of AI in drug discovery is beginning to lead to breakthroughs in understanding disease mechanisms, discovering biomarkers, and developing precision medicine strategies.

The aim of this research topic is to explore the latest developments and applications of AI in drug discovery, identify best practices, and identify their limitations. We seek to highlight innovative original research, methodologies, technology and code, case studies, reviews, and perspectives that utilize AI to enhance the drug discovery pipeline, ultimately seeking to improve the efficacy, efficiency, and success rates of drug development and carry out an honest appraisal of the state of AI in drug discovery.

We invite researchers, practitioners, and industry professionals to contribute articles which might explore but are not limited to:
1. AI-Driven Drug Target Identification: Techniques and applications of AI for identifying novel drug targets and understanding their biological roles using genomic and proteomic data, as well as scientific literature.
2. AI in Virtual Screening and Molecular Docking: Innovations in computational methods for screening large libraries of compounds and understanding their interactions with biological macromolecules; active learning; co-folding.
3. Deep Learning in Quantitative Structure-Activity Relationship (QSAR) and Quantitative Structure-Property Relationship (QSPR) Modelling: Applications of deep learning models to analyse and leverage molecular activity data, predict bioactivity and ADME-Tox (Absorption, Distribution, Metabolism, Excretion, & Toxicity), and guide molecular optimization.
4. AI for Drug Repurposing: Strategies that utilize AI and machine learning to discover new therapeutic uses for existing drugs by analysing genetic, pharmacological, and clinical data.
5. Biomarker Discovery through AI: Methods leveraging AI to identify predictive biomarkers for disease progression and drug response, aiding in precision medicine.
6. Integrative AI Approaches for Multi-Omics Data Analysis: Approaches that integrate various -omics datasets (e.g., genomics, transcriptomics, proteomics) using AI to gain holistic insights into complex biological systems for drug discovery.
7. Generative AI for Molecular Design: Structure-based and ligand-based methods to design novel small molecules, molecular glues, peptidomimetics, biologics, including antibodies and nanobodies, and other modalities, such as mRNA vaccine design and delivery.
8. AI for Medicinal Chemistry: including novel methods for reaction and yield prediction, retrosynthesis, synthetic route optimization, and automated synthesis.
9. AI Benchmarking for Drug Discovery: Best practices in the construction of benchmarks, including automated high-throughput experimentation; high-quality training data sets; best practices in model comparison, including statistically sound evaluation.
10. Advances in Synthetic Data Preparation: Advances in the development of new models using synthetic data generated by the application of computational chemistry, including quantum mechanics; biomolecular simulation, including molecular dynamics and free energy perturbation methods; and course-grained methods.
11. Agentic AI and Large Language Models: Advances in the application of Large Language Models (LLMs) combined with computational tools (“agents”), novel agentic frameworks, workflows, and applications.
12. Explainable AI: new methods and applications of explainable AI, interpretable models.

This research topic aims to bring together diverse perspectives and expertise to foster collaborations and advance the understanding of AI’s transformative role in drug discovery. We encourage interdisciplinary submissions that bridge computational sciences with biological and pharmacological research.

Topic Editor Nathan Brown is currently employed by Healx Ltd.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

• Brief Research Report
• Case Report
• Data Report
• Editorial
• General Commentary
• Hypothesis and Theory
• Methods
• Mini Review
• Opinion
• ... View all formats

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Article types

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

• Brief Research Report
• Case Report
• Data Report
• Editorial
• General Commentary
• Hypothesis and Theory
• Methods
• Mini Review
• Opinion
• Original Research
• Perspective
• Review
• Systematic Review
• Technology and Code

Keywords: Artificial Intelligence, Drug Discovery, Machine Learning, Deep Learning, Precision Medicine, Biomarkers, Molecular Docking, Structure-Activity, LLM, Medical Chemistry, Synthetic Data

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

• What is a Research Topic?

  Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

  Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

• Why does Frontiers publish Research Topics? 

  The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

  Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

• Why are Research Topics important for journals?

  As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

  A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

• How do we ensure the quality of articles within Research Topics?

  Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

  In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

• What are the benefits of publishing my article in a Research Topic?

  Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

  As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

  Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

   
• What types of articles can be published in a Research Topic?

  Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

  Check available article types here 

• Can I suggest a new Research Topic? 

  Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

  Suggest your topic here 

• Who leads a Research Topic? 

  A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

  The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

• What is the role of a topic editor?

  As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

   

  You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

• What support will I receive when editing a new Research Topic? 

  As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

• As a junior researcher, can I be involved in editing a Research Topic? 

  If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

• Can I get a certificate for editing a Research Topic?

  Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

• Who will I collaborate with?

  Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

• How long does it take to publish a Research Topic?

  As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

  Find out more about our Research Topics

• What fee support is available to authors publishing in a Research Topic?

  Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

  Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

• Will there be a printed version of my Research Topic?

  In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.